Literature DB >> 271998

Mapping of human chromosomal regions related to neoplasia: evidence from chromosomes 1 and 17.

J D Rowley.   

Abstract

In clonal aberrations leading to an excess or partial excess of chromosome 1, trisomy for bands 1q25-1q32 was noted in the myeloid cells from all of 34 patients who had various disorders such as acute leukemia, polycythemia vera, and myelofibrosis. This was not the result of a particularly fragile site in that region of the chromosome because the break points in reciprocal translocations that involve it occurred almost exclusively in the short arm. Two consistent rearrangements that have been observed in chromosome 17 produced either duplication of the entire long arm or a translocation of the distal portion of the long arm to chromosome 15. The nonrandom chromosomal changes found in hematologic disorders can now be correlated with the gene loci on these chromosomes or chromosomal segments. Seventy-five genes related to various metabolic enzymes have been mapped; it may be significant that chromosomes carrying gene loci related to nucleic acid metabolism are more frequently involved in hematologic disorders (and other malignancies as well) than are gene loci related to intermediary or carbohydrate metabolism. Furthermore, the known virus-human chromosome associations are closely correlated with the chromosomes affected in hematologic disorders. If one of the effects of carcinogens (including viruses) is to activate genes that regulate host cell DNA synthesis, and if translocations or duplications of specific chromosomal segments produce the same effect, then either of these mechanisms might provide the affected cell with a proliferative advantage.

Entities:  

Mesh:

Year:  1977        PMID: 271998      PMCID: PMC431867          DOI: 10.1073/pnas.74.12.5729

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  28 in total

1.  Localization and induction of the human thymidine kinase gene by adenovirus 12.

Authors:  J K McDougall; R Kucherlapati; F H Ruddle
Journal:  Nat New Biol       Date:  1973-10-10

2.  A rapid banding technique for human chromosomes.

Authors:  M Seabright
Journal:  Lancet       Date:  1971-10-30       Impact factor: 79.321

3.  Gene dose effect: regional mapping of human nuceloside phosphorylase on chromosome 14.

Authors:  D L George; U Francke
Journal:  Science       Date:  1976-11-19       Impact factor: 47.728

4.  15/17 translocation, a consistent chromosomal change in acute promyelocytic leukaemia.

Authors:  J D Rowley; H M Golomb; C Dougherty
Journal:  Lancet       Date:  1977-03-05       Impact factor: 79.321

Review 5.  Relationship of chromosome changes to neoplastic cell transformation.

Authors:  J A DiPaolo; N C Popescu
Journal:  Am J Pathol       Date:  1976-12       Impact factor: 4.307

Review 6.  Preleukemia. Cytogenetic clues in some confusing disorders.

Authors:  P C Nowell
Journal:  Am J Pathol       Date:  1977-11       Impact factor: 4.307

7.  Localisation of the human ABO: Np-1: AK-1 linkage group by regional assignment of AK-1 to 9q34.

Authors:  M A Ferguson-Smith; D A Aitken; C Turleau; J de Grouchy
Journal:  Hum Genet       Date:  1976-09-10       Impact factor: 4.132

8.  Chromosome 14 translocation in African and North American Burkitt's lymphoma;.

Authors:  B Kaiser-McCaw; A L Epstein; H S Kaplan; F Hecht
Journal:  Int J Cancer       Date:  1977-04-15       Impact factor: 7.396

9.  Chromosome mapping of the genes that control differentiation and malignancy in myeloid leukemic cells.

Authors:  J I Azumi; L Sachs
Journal:  Proc Natl Acad Sci U S A       Date:  1977-01       Impact factor: 11.205

10.  The status of the gene map of the human chromosomes.

Authors:  V A McKusick; F H Ruddle
Journal:  Science       Date:  1977-04-22       Impact factor: 47.728

View more
  21 in total

1.  Localisation of the gene coding for the haemopoietic stem cell antigen CD34 to chromosome 1q32.

Authors:  S M Howell; H V Molgaard; M F Greaves; N K Spurr
Journal:  Hum Genet       Date:  1991-09       Impact factor: 4.132

2.  Pure trisomy 17p in 60% cells.

Authors:  F Shabtai; A Shalev; J Chemke; I Halbrecht; E Elian
Journal:  Hum Genet       Date:  1979       Impact factor: 4.132

3.  Complete or partial trisomy for the long arm of chromosome 1 in patients with various hematologic malignancies.

Authors:  S E Mamaeva; N N Mamaev; N M Jartseva; L V Belyaeva; E G Scherbakova
Journal:  Hum Genet       Date:  1983       Impact factor: 4.132

4.  Partial trisomy 1 due to 1/17 translocation in Ph'-positive chronic myelocytic leukemia.

Authors:  F Pasquali; D Francesconi; R Casalone; G Ippoliti
Journal:  Hum Genet       Date:  1979-07-18       Impact factor: 4.132

Review 5.  Somatic cell fusion as a source of genetic rearrangement leading to metastatic variants.

Authors:  L Larizza; V Schirrmacher
Journal:  Cancer Metastasis Rev       Date:  1984       Impact factor: 9.264

6.  Neuroepithelioma (neuroblastoma) arising in an adult. A case report.

Authors:  J Verwey; R Slater; W Kamphorst; H M Pinedo
Journal:  J Cancer Res Clin Oncol       Date:  1985       Impact factor: 4.553

7.  Regulation of normal differentiation in mouse and human myeloid leukemic cells by phorbol esters and the mechanism of tumor promotion.

Authors:  J Lotem; L Sachs
Journal:  Proc Natl Acad Sci U S A       Date:  1979-10       Impact factor: 11.205

8.  Loss of heterozygosity in hypotriploid cell cultures from testicular tumours.

Authors:  J M Parrington; L F West; S Povey
Journal:  Hum Genet       Date:  1987-11       Impact factor: 4.132

Review 9.  Mechanisms of action and resistance to all-trans retinoic acid (ATRA) and arsenic trioxide (As2O 3) in acute promyelocytic leukemia.

Authors:  Akihiro Tomita; Hitoshi Kiyoi; Tomoki Naoe
Journal:  Int J Hematol       Date:  2013-05-14       Impact factor: 2.490

Review 10.  Small metacentric marker chromosomes, particularly isochromosomes, in cancer.

Authors:  N B Atkin; M C Baker
Journal:  Hum Genet       Date:  1988-06       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.